Sitaxsentan alone ( DrugBank: Sitaxsentan )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	2

86. Pulmonary arterial hypertension

---

Clinical trials : 1,181 /  Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01251835 (ClinicalTrials.gov)	December 2010	1/12/2010	Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan	A Phase 1, Open Label, Fixed Sequence Design, Multiple Dose Study To Assess The Effect Of Rifampin On The Pharmacokinetics Of Sitaxsentan In Healthy Subjects	Pulmonary Arterial Hypertension	Drug: Sitaxsentan alone;Drug: Sitaxsentan;Drug: Rifampin	Pfizer	NULL	Withdrawn	21 Years	55 Years	Both	0	Phase 1	NULL
2	NCT00796666 (ClinicalTrials.gov)	May 2009	20/11/2008	Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil	A Phase 3, Multi-Center, Randomized, Double-Blind, Efficacy And Safety Study Of Monotherapy Sitaxsentan Sodium Versus Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension Who Have Completed Study B1321001 (NCT00795639)	Pulmonary Arterial Hypertension;Pulmonary Hypertension	Drug: Sitaxsentan;Drug: Sitaxsentan and Sildenafil	Pfizer	NULL	Terminated	16 Years	80 Years	All	131	Phase 3	United States;Argentina;Bulgaria;Chile;China;Colombia;Czech Republic;India;Malaysia;Mexico;Peru;Romania;Russian Federation;Serbia;South Africa;Thailand;Turkey;Ukraine;Costa Rica;Dominican Republic;Philippines;Saudi Arabia;Slovakia